Chief Executive Officer
Tue, Nov 1, 2022
Nov 1
12,500 shares @ $20.03
Decreased holdings by -1.00%
6th largest trade (out of 185)
Trade made by an officer
50% win rate · -3.6% median edge vs SPY (8 trades, 90-day · small sample)
Price 30% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology